Cargando…
Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study
Alternative temozolomide regimens have been proposed to overcome O(6)-methylguanine-DNA methyltransferase mediated resistance. We investigated the efficacy and tolerability of 1 week on/1 week off temozolomide (ddTMZ) regimen in a cohort of patients treated with ddTMZ between 2005 and 2011 for the p...
Autores principales: | Taal, Walter, Segers-van Rijn, Joyce M. W., Kros, Johan M., van Heuvel, Irene, van der Rijt, Carin C. D., Bromberg, Jacoline E., Sillevis Smitt, Peter A. E., van den Bent, Martin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337418/ https://www.ncbi.nlm.nih.gov/pubmed/22396071 http://dx.doi.org/10.1007/s11060-012-0832-5 |
Ejemplares similares
-
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
por: Brandes, A A, et al.
Publicado: (2006) -
The Weekly Day off
Publicado: (1920) -
Current treatment of low grade gliomas
por: van den Bent, Martin J., et al.
Publicado: (2012) -
The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review
por: Swildens, Kyra X, et al.
Publicado: (2022) -
Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma
por: Zeneyedpour, Lona, et al.
Publicado: (2022)